FLUOXETINE
Recalling Firm / Manufacturer: Torrent Pharma Inc.
(Basking Ridge, NJ, United States)
FDA Recall Number: D-0455-2025
Source Authority Disclaimer: This drug recall notice is published by Questo using official enforcement reports issued by the U.S. Food & Drug Administration (FDA). It is provided for informational, academic, and clinical research purposes only. Patients should not discontinue prescribed treatments without consulting their physician or pharmacist.
Product & Identification Information
Brand, active ingredients, NDC codes, and manufacturer details
Brand / Trade Name
FLUOXETINE
Generic Name
FLUOXETINE
Active Substance(s)
Fluoxetine Hydrochloride
Administration Route
Oral
National Drug Code (NDC)
13668-443
Total Quantity Recalled
3672 Bottles
Official Reason for Recall
Specific hazard or quality defect cited by the FDA
According to the official FDA enforcement report:
CGMP Deviations: Presence of N-Nitroso Fluoxetine exceeding interim acceptable intake limit.
Full Product Description
Packaging specifications and labeling details
Fluoxetine Tablets, USP, 20 mg, 30-count bottle, Rx only, Manufactured by: TORRENT PHARMACEUTIALS LTD., Indrad-382 721 INDIA; Manufactured for: TORRENT PHARMA INC., Basking Ridge, NJ 07920. NDC: 13668-473-30
Enforcement & Regulatory Details
FDA classification, report dates, and initiation authority
Health Hazard Classification
Class II
Current Action Status
Completed
FDA Enforcement Report Date
June 11, 2025
Firm Initiation Date
May 27, 2025
FDA Classification Date
Jun 02, 2025
Initiation Type
Voluntary: Firm initiated
Affected Lots & Batch Numbers
Product codes, lot numbers, and expiration dates
Lot# BDX6K001; Exp. Date 06/30/2025
Distribution Information
Geographic scope of affected shipments
U.S. Nationwide.
Safety Guidance & Actions
Standard FDA protocol for patients and healthcare providers
Patient Advisory
Check your prescription bottle or packaging against the affected lot numbers listed above. If your medication matches a recalled lot, contact your pharmacist for replacement guidance.
Healthcare Provider Guidance
Audit pharmacy stock and return affected lots to the distributor per manufacturer instructions. Notify patients where clinically indicated.
Official Source Provenance
Verified regulatory citation from U.S. FDA OpenFDA
Primary Data Source: U.S. Food & Drug Administration (FDA) OpenFDA API
Recall Number: D-0455-2025
Questo Retrieval Date: July 31, 2026 14:36 1785508616UTCC